Cargando…
Expression of CCL2/CCR2 signaling proteins in breast carcinoma cells is associated with invasive progression
Ductal carcinoma in situ (DCIS) is the most common type of pre-invasive breast cancer diagnosed in women. Because the majority of DCIS cases are unlikely to progress to invasive breast cancer, many women are over-treated for DCIS. By understanding the molecular basis of early stage breast cancer pro...
Autores principales: | Fang, Wei Bin, Sofia Acevedo, Diana, Smart, Curtis, Zinda, Brandon, Alissa, Nadia, Warren, Kyle, Fraga, Garth, Huang, Li-Ching, Shyr, Yu, Li, Wei, Xie, Lu, Staggs, Vincent, Hong, Yan, Behbod, Fariba, Cheng, Nikki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062684/ https://www.ncbi.nlm.nih.gov/pubmed/33888841 http://dx.doi.org/10.1038/s41598-021-88229-0 |
Ejemplares similares
-
CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments
por: Brummer, Gage, et al.
Publicado: (2019) -
Role of ALDH1A1 and HTRA2 expression in CCL2/CCR2-mediated breast cancer cell growth and invasion
por: Hu, Qingting, et al.
Publicado: (2019) -
Regulation of growth, invasion and metabolism of breast ductal carcinoma through CCL2/CCR2 signaling interactions with MET receptor tyrosine kinases
por: Acevedo, Diana Sofía, et al.
Publicado: (2022) -
CCL2, CCR2 Gene Variants and CCL2, CCR2 Serum Levels Association with Age-Related Macular Degeneration
por: Gudauskiene, Gaile, et al.
Publicado: (2022) -
CCL2/CCR2 signaling in cancer pathogenesis
por: Hao, Qiongyu, et al.
Publicado: (2020)